Table: Immuno Biological Lab -Q1 group results

Immuno-Biological Laboratories

08/08/2025 07:39

Aug 8 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            211 mln             229 mln           1.03     
                 (-7.9 pct)          (+29.6 pct)      (+5.7 pct)  
  Operating        54 mln              51 mln           240 mln   
                 (+5.4 pct)                           (+14.6 pct) 
  Recurring        57 mln              56 mln           240 mln   
                 (+1.7 pct)         (+318.5 pct)      (+14.4 pct) 
  Net              60 mln              51 mln           265 mln   
                 (+18.7 pct)        (+359.9 pct)      (+6.4 pct)  
  EPS             6.54 yen            5.51 yen         28.45 yen  
  Ann Div                                NIL           6.00 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL           6.00 yen   
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T